The Landscape of Emerging Randomized Clinical Trial Evidence for COVID-19 Disease Stages: A Systematic Review of Global Trial Registries.

Alison DillmanMichael J ZorattiJay J H ParkGrace G HsuLouis DronGerald SmithOfir HarariCraig R RaynerNoor-E ZannatAlind GuptaEric MackayPaul AroraZelyn LeeEdward J Mills

Published in: Infection and drug resistance (2020)

There is a marked difference in the number of trials across settings, with limited studies on non-hospitalized persons. Focus on pre- and post-exposure, and outpatients, is worthwhile as a means of reducing infections and lessening the health, social, and economic burden of COVID-19.

Keyphrases

coronavirus disease
sars cov
healthcare
mental health
public health
clinical trial
study protocol
respiratory syndrome coronavirus
phase iii
health information
randomized controlled trial
double blind
case control
human health
climate change
placebo controlled